References
[1] J. Wang, Y. Mao, Y. Liu, Z. Chen, M. Chen, X. Lao, S. Li, ”Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment,” J Gastrointest Surg, Apr 10 2017.
[2] A. Huang, X. R. Yang, W. Y. Chung, A. R. Dennison, J. Zhou, ”Targeted therapy for hepatocellular carcinoma,” Signal Transduct Target Ther, vol. 5, p. 146, Aug 11 2020.
[3] T. Usui, M. Sakurai, S. Enjoji, H. Kawasaki, K. Umata, T. Ohama, N. Fujiwara, R. Yabe, S. Tsuji, H. Yamawaki, S. Hazama, H. Takenouchi, M. Nakajima, R. Tsunedomi, N. Suzuki, H. Nagano, K. Sato, ”Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment,” Stem Cells Int, vol. 2016, p. 7053872, 2016.
[4] Y. Yu, Y. Wang, X. Xiao, W. Cheng, L. Hu, W. Yao, Z. Qian, W. Wu, ”MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1,”Biochemistry and cell biology = Biochimie et biologie cellulaire,vol. 97, pp. 563-570, 2019.
[5] V. Kumarasamy, P. Vail, R. Nambiar, A. K. Witkiewicz, E. S. Knudsen, ”Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition,”Cancer Res, vol. 81, pp. 1347-1360, Mar 1 2021.
[6] M. van de Wetering, H. E. Francies, J. M. Francis, G. Bounova, F. Iorio, A. Pronk, W. van Houdt, J. van Gorp, A. Taylor-Weiner, L. Kester, A. McLaren-Douglas, J. Blokker, S. Jaksani, S. Bartfeld, R. Volckman, P. van Sluis, V. S. Li, S. Seepo, C. Sekhar Pedamallu, K. Cibulskis, S. L. Carter, A. McKenna, M. S. Lawrence, L. Lichtenstein, C. Stewart, J. Koster, R. Versteeg, A. van Oudenaarden, J. Saez-Rodriguez, R. G. Vries, G. Getz, L. Wessels, M. R. Stratton, U. McDermott, M. Meyerson, M. J. Garnett, H. Clevers, ”Prospective derivation of a living organoid biobank of colorectal cancer patients,” Cell, vol. 161, pp. 933-45, May 7 2015.
[7] A. Bruna, O. M. Rueda, W. Greenwood, A. S. Batra, M. Callari, R. N. Batra, K. Pogrebniak, J. Sandoval, J. W. Cassidy, A. Tufegdzic-Vidakovic, S. J. Sammut, L. Jones, E. Provenzano, R. Baird, P. Eirew, J. Hadfield, M. Eldridge, A. McLaren-Douglas, A. Barthorpe, H. Lightfoot, M. J. O’Connor, J. Gray, J. Cortes, J. Baselga, E. Marangoni, A. L. Welm, S. Aparicio, V. Serra, M. J. Garnett, C. Caldas, ”A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds,”Cell, vol. 167, pp. 260-274 e22, Sep 22 2016.
[8] K. A. Naipal, N. S. Verkaik, H. Sanchez, C. H. van Deurzen, M. A. den Bakker, J. H. Hoeijmakers, R. Kanaar, M. P. Vreeswijk, A. Jager, D. C. van Gent, ”Tumor slice culture system to assess drug response of primary breast cancer,” BMC Cancer, vol. 16, p. 78, Feb 9 2016.
[9] J. A. Hickman, R. Graeser, R. de Hoogt, S. Vidic, C. Brito, M. Gutekunst, H. van der Kuip, I. P. Consortium, ”Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo,”Biotechnol J, vol. 9, pp. 1115-28, Sep 2014.
[10] D. L. Holliday, M. A. Moss, S. Pollock, S. Lane, A. M. Shaaban, R. Millican-Slater, C. Nash, A. M. Hanby, V. Speirs, ”The practicalities of using tissue slices as preclinical organotypic breast cancer models,” J Clin Pathol,vol. 66, pp. 253-5, Mar 2013.
[11] M. Zeng, Q.-R. Yang, G.-B. Fu, Y. Zhang, X. Zhou, W.-J. Huang, H.-D. Zhang, W.-J. Li, Z.-Y. Wang, H.-X. Yan, B. Zhai, ”Maintaining viability and characteristics of cholangiocarcinoma tissue by vitrification-based cryopreservation,”Cryobiology, vol. 78, pp. 41-46, 2017.
[12] E. J. Chadwick, D. P. Yang, M. G. Filbin, E. Mazzola, Y. Sun, O. Behar, M. F. Pazyra-Murphy, L. Goumnerova, K. L. Ligon, C. D. Stiles, R. A. Segal, ”A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies,” Journal of Visualized Experiments, vol. 105 p. e53304, 2015.
[13] H. A. Kenny, M. Lal-Nag, E. A. White, M. Shen, C. Y. Chiang, A. K. Mitra, Y. Zhang, M. Curtis, E. M. Schryver, S. Bettis, A. Jadhav, M. B. Boxer, Z. Li, M. Ferrer, E. Lengyel, ”Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy,”Nat Commun, vol. 6, p. 6220, Feb 5 2015.
[14] N. Parajuli and W. Doppler, ”Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs,” In Vitro Cell Dev Biol Anim, vol. 45, pp. 442-50, Sep 2009.
[15] M. M. Gerlach, F. Merz, G. Wichmann, C. Kubick, C. Wittekind, F. Lordick, A. Dietz, I. Bechmann, ”Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance,” Br J Cancer, vol. 110, pp. 479-88, Jan 21 2014.
[16] S. E. Burdall, A. M. Hanby, M. R. Lansdown, V. Speirs, ”Breast cancer cell lines: friend or foe?,”Breast Cancer Res, vol. 5, pp. 89-95, 2003.
[17] S. F. Boj, C. I. Hwang, L. A. Baker, Chio, II, D. D. Engle, V. Corbo, M. Jager, M. Ponz-Sarvise, H. Tiriac, M. S. Spector, A. Gracanin, T. Oni, K. H. Yu, R. van Boxtel, M. Huch, K. D. Rivera, J. P. Wilson, M. E. Feigin, D. Ohlund, A. Handly-Santana, C. M. Ardito-Abraham, M. Ludwig, E. Elyada, B. Alagesan, G. Biffi, G. N. Yordanov, B. Delcuze, B. Creighton, K. Wright, Y. Park, F. H. Morsink, I. Q. Molenaar, I. H. Borel Rinkes, E. Cuppen, Y. Hao, Y. Jin, I. J. Nijman, C. Iacobuzio-Donahue, S. D. Leach, D. J. Pappin, M. Hammell, D. S. Klimstra, O. Basturk, R. H. Hruban, G. J. Offerhaus, R. G. Vries, H. Clevers, D. A. Tuveson, ”Organoid models of human and mouse ductal pancreatic cancer,” Cell, vol. 160, pp. 324-38, Jan 15 2015.
[18] H. van der Kuip, T. E. Murdter, M. Sonnenberg, M. McClellan, S. Gutzeit, A. Gerteis, W. Simon, P. Fritz, W. E. Aulitzky, ”Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment,” BMC Cancer, vol. 6, p. 86, Apr 7 2006.
[19] L. A. Schwerdtfeger, N. J. Nealon, E. P. Ryan, S. A. Tobet, ”Human colon function ex vivo: Dependence on oxygen and sensitivity to antibiotic,” PLoS One,vol. 14, p. e0217170, 2019.
[20] V. Vaira, G. Fedele, S. Pyne, E. Fasoli, G. Zadra, D. Bailey, E. Snyder, A. Faversani, G. Coggi, R. Flavin, S. Bosari, M. Loda, ”Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors,” Proc Natl Acad Sci U S A, vol. 107, pp. 8352-6, May 4 2010.
[21] L. Vesci, V. Carollo, G. Roscilli, L. Aurisicchio, F. F. Ferrara, L. Spagnoli, R. De Santis, ”Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance,” Oncol Rep, vol. 34, pp. 1146-52, Sep 2015.
[22] S. H. Grosso, M. L. Katayama, R. A. Roela, S. Nonogaki, F. A. Soares, H. Brentani, L. Lima, M. A. Folgueira, A. F. Waitzberg, F. S. Pasini, J. C. Goes, M. M. Brentani, ”Breast cancer tissue slices as a model for evaluation of response to rapamycin,” Cell Tissue Res, vol. 352, pp. 671-84, Jun 2013.
[23] F. Unger, S. Bentz, J. Kruger, C. Rosenbrock, J. Schaller, K. Pursche, A. Sprussel, H. Juhl, K. David, ”Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing,”Journal of Molecular Pathophysiology, vol. 4, p. 108, 2015.
[24] E. J. Davies, M. Dong, M. Gutekunst, K. Narhi, H. J. van Zoggel, S. Blom, A. Nagaraj, T. Metsalu, E. Oswald, S. Erkens-Schulze, J. A. Delgado San Martin, R. Turkki, S. R. Wedge, T. M. af Hallstrom, J. Schueler, W. M. van Weerden, E. W. Verschuren, S. T. Barry, H. van der Kuip, J. A. Hickman, ”Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices,” Sci Rep, vol. 5, p. 17187, Dec 9 2015.
[25] S. L. Maund, R. Nolley, D. M. Peehl, ”Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate,”Lab Invest, vol. 94, pp. 208-21, Feb 2014.
[26] F. Karimi-Busheri, A. Rasouli-Nia, M. Weinfeld, ”Key Issues Related to Cryopreservation and Storage of Stem Cells and Cancer Stem Cells: Protecting Biological Integrity,” Adv Exp Med Biol, vol. 951, pp. 1-12, 2016.
[27] M. Ochota, B. Wojtasik, W. Nizanski, ”Survival rate after vitrification of various stages of cat embryos and blastocyst with and without artificially collapsed blastocoel cavity,” Reprod Domest Anim, vol. 52 Suppl 2, pp. 281-287, Apr 2017.
[28] E. Elder, Z. Chen, A. Ensley, R. Nerem, K. Brockbank, Y. Song, ”Enhanced tissue strength in cryopreserved, collagen-based blood vessel constructs,” Transplant Proc, vol. 37, pp. 4625-9, Dec 2005.